Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)
- Status
- COMPLETED
- Phase
- PHASE2
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Deep vs Moderate Neuromuscular Blockade With Rocuronium in Patients Undergoing Endolaryngeal Procedures
- Status
- COMPLETED
- Phase
- PHASE4
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacokinetics of Tedizolid Phosphate in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE4
Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
- Status
- UNKNOWN
- Phase
- NA
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Placental Passage and Disposition of Drugs: A Physiology-based Approach
- Status
- RECRUITING
- Phase
- N/A
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1